As of 2025-04-20, the EV/EBITDA ratio of Vir Biotechnology Inc (VIR) is -0.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VIR's latest enterprise value is 531.32 mil USD. VIR's TTM EBITDA according to its financial statements is -539.83 mil USD. Dividing these 2 quantities gives us the above VIR EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 13.4x | 12.1x |
| Forward P/E multiples | 14.0x - 15.0x | 14.4x |
| Fair Price | (53.33) - (50.96) | (50.53) |
| Upside | -1069.6% - -1026.6% | -1018.7% |
| Date | EV/EBITDA |
| 2025-04-17 | -0.98 |
| 2025-04-16 | -0.97 |
| 2025-04-15 | -1.01 |
| 2025-04-14 | -1.00 |
| 2025-04-11 | -0.99 |
| 2025-04-10 | -0.93 |
| 2025-04-09 | -1.04 |
| 2025-04-08 | -0.91 |
| 2025-04-07 | -0.99 |
| 2025-04-04 | -1.00 |
| 2025-04-03 | -1.10 |
| 2025-04-02 | -1.23 |
| 2025-04-01 | -1.16 |
| 2025-03-31 | -1.23 |
| 2025-03-28 | -1.29 |
| 2025-03-27 | -1.28 |
| 2025-03-26 | -1.26 |
| 2025-03-25 | -1.35 |
| 2025-03-24 | -1.42 |
| 2025-03-21 | -1.35 |
| 2025-03-20 | -1.33 |
| 2025-03-19 | -1.35 |
| 2025-03-18 | -1.35 |
| 2025-03-17 | -1.37 |
| 2025-03-14 | -1.40 |
| 2025-03-13 | -1.37 |
| 2025-03-12 | -1.45 |
| 2025-03-11 | -1.45 |
| 2025-03-10 | -1.46 |
| 2025-03-07 | -1.61 |
| 2025-03-06 | -1.64 |
| 2025-03-05 | -1.68 |
| 2025-03-04 | -1.67 |
| 2025-03-03 | -1.60 |
| 2025-02-28 | -1.72 |
| 2025-02-27 | -1.65 |
| 2025-02-26 | -1.92 |
| 2025-02-25 | -1.90 |
| 2025-02-24 | -1.99 |
| 2025-02-21 | -2.02 |
| 2025-02-20 | -2.08 |
| 2025-02-19 | -2.09 |
| 2025-02-18 | -2.05 |
| 2025-02-14 | -2.04 |
| 2025-02-13 | -2.02 |
| 2025-02-12 | -1.90 |
| 2025-02-11 | -1.89 |
| 2025-02-10 | -1.97 |
| 2025-02-07 | -2.09 |
| 2025-02-06 | -2.19 |